Logo image of CON

CONCENTRA GROUP HOLDINGS PAR (CON) Stock Fundamental Analysis

NYSE:CON - US20603L1026 - Common Stock

23.35 USD
+0.49 (+2.14%)
Last: 8/27/2025, 4:10:04 PM
23.35 USD
0 (0%)
After Hours: 8/27/2025, 4:10:04 PM
Fundamental Rating

5

Overall CON gets a fundamental rating of 5 out of 10. We evaluated CON against 101 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of CON while its profitability can be described as average. CON has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CON had positive earnings in the past year.
In the past year CON had a positive cash flow from operations.
CON Yearly Net Income VS EBIT VS OCF VS FCFCON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 200M 400M 600M

1.2 Ratios

CON has a Return On Assets of 5.24%. This is amongst the best in the industry. CON outperforms 81.19% of its industry peers.
CON has a better Return On Equity (43.45%) than 98.02% of its industry peers.
CON's Return On Invested Capital of 10.98% is amongst the best of the industry. CON outperforms 83.17% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CON is significantly above the industry average of 9.14%.
The last Return On Invested Capital (10.98%) for CON is well below the 3 year average (23.70%), which needs to be investigated, but indicates that CON had better years and this may not be a problem.
Industry RankSector Rank
ROA 5.24%
ROE 43.45%
ROIC 10.98%
ROA(3y)14.38%
ROA(5y)N/A
ROE(3y)62.08%
ROE(5y)N/A
ROIC(3y)23.71%
ROIC(5y)N/A
CON Yearly ROA, ROE, ROICCON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 20 40 60 80 100

1.3 Margins

With an excellent Profit Margin value of 7.42%, CON belongs to the best of the industry, outperforming 88.12% of the companies in the same industry.
In the last couple of years the Profit Margin of CON has declined.
Looking at the Operating Margin, with a value of 15.66%, CON belongs to the top of the industry, outperforming 92.08% of the companies in the same industry.
CON's Operating Margin has declined in the last couple of years.
CON has a Gross Margin (28.10%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CON has declined.
Industry RankSector Rank
OM 15.66%
PM (TTM) 7.42%
GM 28.1%
OM growth 3Y-3.12%
OM growth 5YN/A
PM growth 3Y-10.09%
PM growth 5YN/A
GM growth 3Y-1.93%
GM growth 5YN/A
CON Yearly Profit, Operating, Gross MarginsCON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 5 10 15

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CON is creating value.
Compared to 1 year ago, CON has more shares outstanding
Compared to 1 year ago, CON has a worse debt to assets ratio.
CON Yearly Shares OutstandingCON Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M 80M 100M
CON Yearly Total Debt VS Total AssetsCON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

CON has an Altman-Z score of 1.84. This is not the best score and indicates that CON is in the grey zone with still only limited risk for bankruptcy at the moment.
CON's Altman-Z score of 1.84 is in line compared to the rest of the industry. CON outperforms 44.55% of its industry peers.
CON has a debt to FCF ratio of 8.91. This is a slightly negative value and a sign of low solvency as CON would need 8.91 years to pay back of all of its debts.
The Debt to FCF ratio of CON (8.91) is comparable to the rest of the industry.
A Debt/Equity ratio of 4.82 is on the high side and indicates that CON has dependencies on debt financing.
CON has a worse Debt to Equity ratio (4.82) than 80.20% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.82
Debt/FCF 8.91
Altman-Z 1.84
ROIC/WACC1.31
WACC8.39%
CON Yearly LT Debt VS Equity VS FCFCON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 500M 1B

2.3 Liquidity

A Current Ratio of 1.18 indicates that CON should not have too much problems paying its short term obligations.
The Current ratio of CON (1.18) is worse than 61.39% of its industry peers.
CON has a Quick Ratio of 1.18. This is a normal value and indicates that CON is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.18, CON perfoms like the industry average, outperforming 42.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 1.18
CON Yearly Current Assets VS Current LiabilitesCON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 100M 200M 300M 400M

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 2.72% over the past year.
CON shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -3.99% yearly.
The Revenue has been growing slightly by 3.38% in the past year.
Measured over the past years, CON shows a small growth in Revenue. The Revenue has been growing by 3.14% on average per year.
EPS 1Y (TTM)2.72%
EPS 3Y-3.99%
EPS 5YN/A
EPS Q2Q%-26%
Revenue 1Y (TTM)3.38%
Revenue growth 3Y3.14%
Revenue growth 5YN/A
Sales Q2Q%15.25%

3.2 Future

The Earnings Per Share is expected to grow by 8.09% on average over the next years. This is quite good.
Based on estimates for the next years, CON will show a quite strong growth in Revenue. The Revenue will grow by 9.01% on average per year.
EPS Next Y-6.62%
EPS Next 2Y5.41%
EPS Next 3Y8.09%
EPS Next 5YN/A
Revenue Next Year13.08%
Revenue Next 2Y10.45%
Revenue Next 3Y9.01%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CON Yearly Revenue VS EstimatesCON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CON Yearly EPS VS EstimatesCON Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 18.98 indicates a rather expensive valuation of CON.
Based on the Price/Earnings ratio, CON is valued a bit cheaper than the industry average as 74.26% of the companies are valued more expensively.
CON is valuated rather cheaply when we compare the Price/Earnings ratio to 27.08, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 14.93, CON is valued correctly.
CON's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CON is cheaper than 75.25% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.67. CON is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 18.98
Fwd PE 14.93
CON Price Earnings VS Forward Price EarningsCON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CON indicates a somewhat cheap valuation: CON is cheaper than 64.36% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CON is valued a bit cheaper than the industry average as 75.25% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 16.01
EV/EBITDA 11.88
CON Per share dataCON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 15

4.3 Compensation for Growth

The decent profitability rating of CON may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.41%
EPS Next 3Y8.09%

3

5. Dividend

5.1 Amount

CON has a Yearly Dividend Yield of 1.09%.
Compared to an average industry Dividend Yield of 2.51, CON pays a better dividend. On top of this CON pays more dividend than 85.15% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, CON's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.09%

5.2 History

CON is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
CON Yearly Dividends per shareCON Yearly Dividends per shareYearly Dividends per share 2024 2025 0.05 0.1 0.15

5.3 Sustainability

16.11% of the earnings are spent on dividend by CON. This is a low number and sustainable payout ratio.
DP16.11%
EPS Next 2Y5.41%
EPS Next 3Y8.09%
CON Yearly Income VS Free CF VS DividendCON Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 100M 200M 300M 400M 500M
CON Dividend Payout.CON Dividend Payout, showing the Payout Ratio.CON Dividend Payout.PayoutRetained Earnings

CONCENTRA GROUP HOLDINGS PAR

NYSE:CON (8/27/2025, 4:10:04 PM)

After market: 23.35 0 (0%)

23.35

+0.49 (+2.14%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)10-27 2025-10-27
Inst Owners84.54%
Inst Owner Change-13.05%
Ins Owners7.38%
Ins Owner Change0%
Market Cap2.99B
Analysts81.67
Price Target28.27 (21.07%)
Short Float %3.06%
Short Ratio4.04
Dividend
Industry RankSector Rank
Dividend Yield 1.09%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP16.11%
Div Incr Years0
Div Non Decr Years1
Ex-Date08-21 2025-08-21 (0.0625)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.03%
Min EPS beat(2)-2.63%
Max EPS beat(2)0.58%
EPS beat(4)3
Avg EPS beat(4)0.6%
Min EPS beat(4)-2.63%
Max EPS beat(4)3.19%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.68%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)1.48%
Revenue beat(4)1
Avg Revenue beat(4)-0.25%
Min Revenue beat(4)-1.59%
Max Revenue beat(4)1.48%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.52%
EPS NQ rev (1m)-5.31%
EPS NQ rev (3m)-0.38%
EPS NY rev (1m)-3.33%
EPS NY rev (3m)-1.9%
Revenue NQ rev (1m)0.31%
Revenue NQ rev (3m)4.55%
Revenue NY rev (1m)0.84%
Revenue NY rev (3m)1.07%
Valuation
Industry RankSector Rank
PE 18.98
Fwd PE 14.93
P/S 1.49
P/FCF 16.01
P/OCF 11.52
P/B 8.73
P/tB N/A
EV/EBITDA 11.88
EPS(TTM)1.23
EY5.27%
EPS(NY)1.56
Fwd EY6.7%
FCF(TTM)1.46
FCFY6.25%
OCF(TTM)2.03
OCFY8.68%
SpS15.65
BVpS2.67
TBVpS-10.89
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.24%
ROE 43.45%
ROCE 12.54%
ROIC 10.98%
ROICexc 11.32%
ROICexgc 39.62%
OM 15.66%
PM (TTM) 7.42%
GM 28.1%
FCFM 9.32%
ROA(3y)14.38%
ROA(5y)N/A
ROE(3y)62.08%
ROE(5y)N/A
ROIC(3y)23.71%
ROIC(5y)N/A
ROICexc(3y)24.7%
ROICexc(5y)N/A
ROICexgc(3y)89.31%
ROICexgc(5y)N/A
ROCE(3y)27.06%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-3.12%
OM growth 5YN/A
PM growth 3Y-10.09%
PM growth 5YN/A
GM growth 3Y-1.93%
GM growth 5YN/A
F-Score4
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 4.82
Debt/FCF 8.91
Debt/EBITDA 4.34
Cap/Depr 109.56%
Cap/Sales 3.63%
Interest Coverage 3.72
Cash Conversion 68.22%
Profit Quality 125.56%
Current Ratio 1.18
Quick Ratio 1.18
Altman-Z 1.84
F-Score4
WACC8.39%
ROIC/WACC1.31
Cap/Depr(3y)84.37%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.64%
Cap/Sales(5y)N/A
Profit Quality(3y)135.77%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.72%
EPS 3Y-3.99%
EPS 5YN/A
EPS Q2Q%-26%
EPS Next Y-6.62%
EPS Next 2Y5.41%
EPS Next 3Y8.09%
EPS Next 5YN/A
Revenue 1Y (TTM)3.38%
Revenue growth 3Y3.14%
Revenue growth 5YN/A
Sales Q2Q%15.25%
Revenue Next Year13.08%
Revenue Next 2Y10.45%
Revenue Next 3Y9.01%
Revenue Next 5YN/A
EBIT growth 1Y6.25%
EBIT growth 3Y-0.08%
EBIT growth 5YN/A
EBIT Next Year37.66%
EBIT Next 3Y18.3%
EBIT Next 5YN/A
FCF growth 1Y21.47%
FCF growth 3Y-3.19%
FCF growth 5YN/A
OCF growth 1Y17.23%
OCF growth 3Y-1.87%
OCF growth 5YN/A